FOLFOXIRI plus bevacizumab as standard of care for first-line treatment in patients with advanced colon cancer

por Cervantes, A., Prager, G.W.
Publicado 2023

Applied precision cancer medicine in metastatic biliary tract cancer

por Taghizadeh, H., Müllauer, L., Mader, R., Prager, G. W.
Publicado 2020

How we treat esophageal squamous cell carcinoma

por Puhr, H.C., Prager, G.W., Ilhan-Mutlu, A.
Publicado 2023

Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review

por Arnold, D, Prager, G W, Quintela, A, Stein, A, Moreno Vera, S, Mounedji, N, Taieb, J
Publicado 2018

Applied Precision Cancer Medicine in Neuro-Oncology

por Taghizadeh, H., Müllauer, L., Furtner, J., Hainfellner, J. A., Marosi, C., Preusser, M., Prager, G. W.
Publicado 2019

Clinical risk factors for ascites in metastatic pancreatic cancer

por Berger, J.M., Alany, A., Puhr, R., Berchtold, L., Friedrich, A., Scheiner, B., Prager, G.W., Berghoff, A.S., Preusser, M., Bergen, E.S.
Publicado 2023